joseph d. tariman, phd, rn, anp-bc, faan · 2020. 11. 27. · joseph d. tariman. phd, rn, anp-bc,...

Joseph D. Tariman. PhD, RN, ANP-BC, FAAN 1

JOSEPH D. TARIMAN, PhD, RN, ANP-BC, FAAN

Curriculum Vitae

CONTACT INFORMATION

School of Nursing

College of Science and Health

DePaul University

990 W. Fullerton Avenue Suite 3000

Chicago, IL 60614

USA

Telephone: 773-325-2288

Fax: 773-325-7282

Email: [email protected]

EDUCATION

Ph. D. in Nursing Science University of Washington-Seattle, 2011

Major: Biobehavioral Nursing and Health Services

Dissertation Title: Treatment Decision Making in Older Adults

Diagnosed with Symptomatic Myeloma

Master in Business Administration DePaul University, 9/2019-

Major: Management

Expected date of graduation, June 2021

Post-MSN NP Certificate University of Miami - Coral Gables, FL, 2001

Major: Adult Health

Master of Arts in Nursing Cebu Doctors’ University, Philippines, 1993

Major: Medical-Surgical Nursing

Thesis: Incidence of Nosocomial Infections in the ICU Unit

Bachelor of Science in Nursing University of the Visayas, Philippines, 1991

Generalist Nursing

Graduated Cum Laude

ACADEMIC APPOINTMENTS

Associate Professor DePaul University, July 1, 2020 - present

With tenure School of Nursing: Adult-Gerontology Nurse Practitioner Track

Doctor of Nursing Practice Program

Assistant Professor DePaul University, March 2014- June 2020

School of Nursing: Adult-Gerontology Nurse Practitioner Track

Doctor of Nursing Practice Program

Associate Professor (Adjunct) Cebu Doctors’ University (Philippines), July 2020-present

Assistant Professor (Adjunct) Cebu Doctors’ University (Philippines), 2016-June 2020t


Graduate School Department: Ph.D. in Nursing Science Program

Master in Health Administration Program

Clinical Instructor II Cebu Doctors' University (Philippines), 1991-1995

Bachelor of Science in Nursing Medical-Surgical Faculty Team

Predoctoral Research Fellow University of Washington-Seattle, 2009-2011

NIH-National Research Service Award

1F31NR011124-01A1

Investigated the treatment decision making process of older adults

newly diagnosed with symptomatic multiple myeloma

Predoctoral Research Fellow University of Washington-Seattle, 2006-2009

Biobehavioral Nursing and Health Services Research Fellowship

NR007106-NIH/NINR

Evaluated the clinical use of a web-based, Electronic Self Report

Assessment-Cancer (ESRA-C) program in a multi-disciplinary,

academic medical center and cancer center

ADMINISTRATIVE APPOINTMENTS

Associate Director for the Doctor of Nursing Practice Program July 1, 2020 – present

Associate Director, Post-MS Certificate Program for NP

DePaul University

Associate Co-Director for the Doctor of Nursing Practice Program April 2018- June 2020

DePaul University

DPU School of Nursing Faculty Representative September 2015 - present

National Hartford Center of Gerontological Nursing Excellence

DePaul Faculty Representative September 2015 – June 2018

American Association of Colleges of Nursing Jonas Scholarship Program

TEACHING EXPERIENCE

Graduate Level Courses Taught

▪ Evidence-based Practice Research (NSG 600), DePaul University, 03/2014-current

▪ Evidence-based Practice Research II (NSG 601), DePaul University, 03/2014-current

▪ DNP Project Practicum (NSG 602), DePaul University, 3/2014-current

▪ Pharmacotherapeutic Implications for the Older Adults (NSG 555), DePaul University, 03/2014-

current

▪ Advanced Gerontological Nursing (NSG 479), DePaul University, 03/2014-current

▪ Pathophysiology for Advanced Practice (NSG 428), DePaul University, 03/2014-current

▪ Pathophysiology and Applied Pharmacology (NSG 429), DePaul University, 4/2016-current

▪ Advanced Physical Assessment Across the Life Span (NSG 460), DePaul University, 06/2014


▪ Advanced Biostatistics and Epidemiology (EDUC 101A), Cebu Doctors’ University, 06/2016-

current

▪ Biostatistics II (EDUC 101B), Cebu Doctors’ University, 06/2016-current

Undergraduate Level Courses Taught

▪ Fundamentals of Nursing Practice (NUR 101), Cebu Doctors’ University, 06/1991-5/1992

▪ Medical-Surgical Nursing Practice I (NUR 301), Cebu Doctors’ University, 6/1992-5/1995

▪ Medical-Surgical Nursing Practice II (NUR 302), Cebu Doctors’ University, 11/1992-5/1995

Hybrid/Blended Online Courses Taught

▪ Evidence-based Practice Research (NSG 600), DePaul University, 03/2015-06/2016

▪ Evidence-based Practice Research II (NSG 601), DePaul University, 09/2015-06/2016

▪ Advanced Physical Assessment Across the Life Span (NSG 460), DePaul University, 06/2014

Fully Online Courses Taught

▪ Evidence-based Practice Research (NSG 600), DePaul University, 03/2016-current

▪ Evidence-based Practice Research II (NSG 601), DePaul University, 09/2016-current

▪ DNP Project Practicum (NSG 602), DePaul University, 01/2016-current

▪ Pharmacotherapeutic Implications for the Older Adults (NSG 555), DePaul University, 09/2016-

current

▪ Advanced Gerontological Nursing (NSG 479), DePaul University, 01/2016-current

▪ Pathophysiology for Advanced Practice (NSG 428), DePaul University, 04/2017-current

▪ *Pathophysiology and Applied Pharmacology (NSG 429), DePaul University, 4/2016-current

*Course was developed during the DPU DOTS Course in Summer 2015

Graduate Student Dissertation Committees

▪ Member, Clinical Psychology Graduate Student, Madison Sunnquist, 01/09/2020 (scheduled)

▪ Member, Clinical Psychology Graduate Student, Abigail Brown, 07/10/2017

▪ Member, Clinical Psychology Graduate Student, Meredyth Evans, 06/04/2015

Graduate Student Doctor of Nursing Practice (DNP) Project Committees

▪ Chair, DNP Adult-Gerontology Nurse Practitioner Student, Rachel Deutsch, ongoing

▪ Chair, DNP Family Nurse Practitioner Student, Alexandria Tarvainis, ongoing

▪ Chair, DNP Family Nurse Practitioner Student, Lilian Allen, June 2020

▪ Chair, DNP Adult-Gerontology Nurse Practitioner Student, Kristen Zdany, 03/25/2019

▪ Chair, DNP Adult-Gerontology Nurse Practitioner Student, Andrea Warzyniec, June 2019

▪ Chair, DNP Adult-Gerontology Nurse Practitioner Student, Caroline Wilson, 04/13/2018

▪ Chair, DNP Nurse Anesthesia Student, Slawomir Bilanicz, 06/01/2018

▪ Chair, DNP Nurse Anesthesia Student, Katie Coletto, 06/03/2016

▪ Member, DNP Family Nurse Practitioner Student, Sarah Jindoyan, ongoing


▪ Member, DNP Family Nurse Practitioner Student, Paige Barber, ongoing

▪ Member, DNP Nurse Anesthesia Student, Austin Tucker, June 2020

▪ Member, DNP Nurse Anesthesia Student, James Wong, August 2020

▪ Member, DNP Family Nurse Practitioner Student, Rita Elue, 03/14/2019

▪ Member, DNP Family Nurse Practitioner Student, Samantha Kornhauser, 03/13/2019

▪ Member, DNP Nurse Anesthesia Student, Saad Iqbal, August 2019

▪ Member, DNP Nurse Anesthesia Student, Lisa Brown, August 2019

▪ Member, DNP Nurse Anesthesia Student, Matthew Lipinski, 06/01/2018

▪ Member, DNP Family Nurse Practitioner Student, Kristina Passarelli, 06/2018

▪ Member, DNP Family Nurse Practitioner Student, Bryan Mullaney, 04/2018

▪ Member, DNP Adult-Gerontology Nurse Practitioner Student, Christina Lattner, 06/2017

▪ Member, DNP Family Nurse Practitioner Student, Carolyn Talbott, 06/2017

▪ Member, DNP Nurse Anesthesia Student, Kelly Lannert, 06/2017

▪ Member, DNP Nurse Anesthesia Student, Dulcie Schippa, 06/2017

▪ Member, DNP Nurse Anesthesia Student, Laura Majewski, 06/2017

▪ Member, DNP Nurse Anesthesia Student, Pauline Tselonis, 06/2017

▪ Member, DNP Nurse Anesthesia Student, Brittany Schuler, 06/2016

▪ Member, DNP Nurse Anesthesia Student, Alaina Murley, 06/2016

▪ Member, DNP Nurse Anesthesia Student, Kyle Mayer, 06/2016

▪ Member, DNP Nurse Anesthesia Student, Julia Feczko, 06/2015

Graduate (Master Entry to Nursing Practice and RN to MS Programs) Student Research Advisor

▪ Alexandra Vacin, MENP Student, Fall 2014-Fall 2015

▪ Alyssa Baker, MENP Student, Spring 2015-Spring 2016

▪ Anndria Cluster, MENP Student, Fall 2016-Summer 2017

▪ Bojan Kojovic, MENP Student, Fall 2016-Summer 2017

▪ Brian Decant, MENP Student, Fall 2016-Summer 2017

▪ Caroline Oliveira, MENP Student, Fall 2014-Fall 2015

▪ Casey Weaver, MENP Student, Spring 2015-Spring 2016

▪ Cassandra Pedersen, MENP Student, Fall 2016-Fall 2017

▪ Elana Schnall, MENP Student, Spring 2015-Spring 2016

▪ Elizabeth Ornelas, MENP Student, Fall 2014-Fall 2015

▪ Elizabeth Ross, MENP Student, Fall 2016-Fall 2017

▪ Emily Schneider, MENP Student, Winter 2018-current

▪ Enisa Mehmeti, MENP Student, Fall 2014-Fall 2015

▪ Ying Lin, MENP Student, Fall 2014-Fall 2015

▪ Jazel Dolores, MENP Student, Fall 2014-Fall 2015

▪ Jennifer Johnson, MENP Student, Spring 2014-Spring 2015

▪ Joshua Stanciu, MENP Student, Winter 2018-current

▪ Kaitlin Adams, MENP Student, Spring 2017-Spring 2018

▪ Katherine Jones, MENP Student, Spring 2014-Spring 2015

▪ Katherine Meilner, MENP Student, Fall 2014-Fall 2015

▪ Laura Guerrieri, MENP Student, Spring 2017-Spring 2018


▪ Laura Lenski, RN-MS Student, Summer 2018-Winter 2019

▪ Mariska VanDenBergh, MENP Student, Fall 2014-Fall 2015

▪ Mary Clare Houlihan, MENP Student, Fall 2015-Fall 2016

▪ Mary Grace Mallari, MENP Student, Winter 2015-Summer 2016

▪ Nadia Spawn, MENP Student, Fall 2014-Fall 2015

▪ Ollie Urbanski, MENP Student, Fall 2018-Spring 2019

▪ Pamela Katz, MENP Student, Fall 2016-Fall 2017

▪ Ryan Malibiran, MENP Student, Spring 2017-Spring 2018

▪ Sadaf Dhorajiwala, MENP Student, Fall 2014-Fall 2015

▪ Sarah McCarter, MENP Student, Fall 2014-Fall 2015

▪ Shandra Melick, MENP Student, Fall 2018-Spring 2019

▪ Tabitha Negrete, MENP Student, Fall 2018-Spring 2019

▪ Theresa Woods, MENP Student, Fall 2018-Spring 2019

▪ Veronica Stanislawski, MENP Student, Fall 2014-Fall 2015

▪ Laura Lenski, RN to MS Student, Fall 2018 – Spring 2019

▪ Rhea Bovee, MENP Student, Fall 2019 – present

▪ Emily Schneider, MENP Student, Fall 2018 – Spring 2019

▪ Sarah Furtado, MENP Student, Spring 2020 – ongoing

▪ Taylor Stallworth, MENP Student, Spring 2020 - ongoing

CLINICAL EXPERIENCE_- Over 20 Years of Clinical Experience___________________________

Nurse Practitioner, Per Diem October 2017 to May 2019

Northwest Oncology and Hematology

Hoffman Estates, IL

Nurse Practitioner May 2002-June 2006; June 2010-

Northwestern University Myeloma Program, Chicago, IL January 2014

Nurse Manager May 2001-May 2002

University of Chicago Hospitals

Bone Marrow Transplant Unit, Chicago, IL

Clinical Nurse II September 1999-May 2001

University of Miami Hospitals Oncology Unit, Miami, FL

Director of Staff Development & Training June 1997-September 1999

American Health care Services, Miami Lakes, FL

IV Home Infusion RN August 1995-1997

Total Care Services, Miami, FL


Pharmaceutical- and Cooperative-Sponsored Research_______________________________

Performed Two Primary Roles as Co-Investigator in the Myeloma Program Research Team at

Northwestern University (2002-2014):

A. Assessment, monitoring, and reporting of side effects and serious adverse events to clinical drug trial sponsors and IRB

B. Authorized designee to sign case report forms and documentation of response to investigational therapy (Form 1572)

• DRUG54767414MMY2002 An Open-label, Multicenter, phase 2 Trial Investigating the Efficacy and Safety of Daratumumab in Subjects with Multiple Myeloma Who Have Received at Least 3

Prior Lines of Therapy (Including a Proteasome Inhibitor and IMiD) or are Double Refractory to

a Proteasome Inhibitor and an IMiD. October 2013-2014.

• CHART MC12R42 Racial Disparities in Myeloma. June 2013-2014.

• NCI USC11M01 Risk Factors for Multiple Myeloma in African Americans, A Genome Wide Association Study (GWAS). June 2011-2014.

• DRUG FRF4998G An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma.

January 2012-December 2014.

• DRUG MFG4809G An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S in Patients with Relapsed or Refractory

t(4;14)-Positive Multiple Myeloma. August 2010 - January 2012.

• DRUG 2011-02 Carfilzomib Myeloma Access Program (C-MAP) study for Relapsed Refractory Myeloma – January 2012 - August 2012.

• DRUG PX-171-010 A Phase 2, Open Label Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols. July 2010 - July 2012

• SWOG 0777: A Randomized Phase III Trial of CC5013 (Lenalidomide, NSC-703813) and Low Dose Dexamethasone (LLD) Versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low

Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple

Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant. June 2010 -

October 2013.

• NU00X3 Pathology Core Facility Bio Banking. June 2010 - December 2014.

• CC-5013-MM-016 Lenalidomide Expanded Access Program for Patients with Relapsed and/or refractory MM. November 2005-March 2006.

• ECOG4A03 A Randomized Phase III Study of CC-5013 plus Dexamethasone versus CC-5013 plus Low Dose Dexamethasone in Multiple Myeloma with Thalidomide plus Dexamethasone

Salvage Therapy for Non-Responders – May 2005 to March 2006.

• An Open-Label Phase II Trial of Motexafin Gadolinium (MGD) in Patients with Relapsed or Refractory Multiple Myeloma. Sub-Investigator – November 2004 to March 2006.

• CC-5013-MM-014: A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent CC-5013 in Subjects with relapsed and Refractory Multiple Myeloma.

Sub-Investigator – July 2003 to March 2006.

• CC-5013-MM-009: A Multicenter, Randomized, Parallel-Group, Double-Blinded, Placebo-Controlled Study of CC-5013 Plus Dexamethasone in Previously Treated Subjects with Multiple

Myeloma. Sub-Investigator – May 2003 to June 2004.


• E1A00: A Randomized Phase III trial of Thalidomide Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma. Sub-Investigator – January 2003 to May

2004.

• M34102-052: An Open-Label, Randomized Study to Assess Two different Strategies of Combining Dexamethasone with Velcade in Patients with Relapsed Multiple Myeloma who Have

Failed Four or More Lines of Therapy. Sub-Investigator – January 2003 to May 2003.

• M34101-040: An International, Non-Comparative, Open Label Study of PS-341 Administered to Patients with Multiple Myeloma Who Experienced Relapsed or Progressive Disease After

Receiving At Least Four Previous Treatment Regimens or Experienced Progressive Disease After

Receiving Dexamethasone in Millennium Protocol M34101-039. Sub-Investigator – February

2002 to May 2003.

• An International, Multi-Center, Randomized, Open Label Study of PS-341 Versus High-Dose Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Protocol M34101-

039. Sub-Investigator – February 2002 to May 2003.

• A phase II, Open Label, Extension Study to Provide PS-341 to Patients Who Previously Participated in a PS-341 Clinical Study and Who May Benefit from Re-Treatment with or

Continuation of PS-341 Therapy Protocol M34101-029. Sub-Investigator – February 2002 to

April 2003.

• A phase II, Open Label Study of PS-341 in Patients with Relapsed/Refractory Myeloma Protocol M34101-025. Sub-Investigator – February 2002 to June 2002.

• Randomized Phase III Study of Dexamethasone With or Without Genasense (Bcl-2 Antisense Oligonucleotide) in Patients with Relapsed or Refractory Multiple Myeloma Protocol GMY302.

Sub-Investigator – February 2002 to May 2003.

NIH, INSTITUTIONAL AND FOUNDATION GRANTS AND SPONSORED RESEARCH

Grants (Pending Review from the NIH Scientific Review Committee)

Development and Usability Testing of a User-Centered MyePDA+SDM Prototype: An

Integrated Myeloma Patient Decision Aid

Application ID: 1 R21 NR019912-01

Date: 01-01-2021 to 12-30-2022

Role: Principal Investigator

Grants (Funded)

Tariman, J. D. "Characterization of novel biomarkers for fatigue in elderly patients receiving

immunomodulatory or proteasome inhibitor chemotherapy," Sponsored by DPU-RFU

Collaborative Pilot Grant, DePaul University, $86,000.00.

Date: December 2015 - July 2017. Completed.


Pre-Doctoral Grants (Funded)

Pre-Doctoral Fellow, Ruth L. Kirschstein National Service Award funded by the National

Institute of Health, National Institute of Nursing Research, Individual Fellowship Grant

#1F31NR011124-01A1. Funding: $49,800 2009-2011.


Project title: Treatment decision making in older adults newly diagnosed with multiple myeloma;

September 2009 – March 2011 (18 months full support).


Sponsors: Barbara Cochrane, PhD, RN, FAAN (University of Washington) & Donna L. Berry,

PhD, RN, FAAN (University of Washington and Dana Farber Cancer Institute). Completed.

Pre-Doctoral Fellow, Ruth L. Kirschstein National Service Award funded by the National Institute

of Health, National Institute of Nursing Research, Institutional Grant #T32 - Training in

Biobehavioral Nursing Research; September 2006 – September 2008 (full support). $75,000 2006-

2009.

Mentor: Donna L. Berry, PhD, RN, FAAN

Research residency: NIH RO1-funded grant: Electronic Self Report Assessment for Cancer

(ESRA-C). Completed.

Sponsored Research

Tariman, J.D., "Development and testing of Shared Decision-Making Scale for Nurses (SDMS-

Nurses). Funded: Chicago Chapter Oncology Nursing Society, Local, $6,000. (January 2017 -

August 2017). Completed.

Tariman, J. D., "An Internet-Based Survey on Health Maintenance and Preventive Care Patterns

in Myeloma Patients," Sponsored by International Myeloma Foundation, Private, $1,500.00.

(June 2013 - September 2014).

Role: Principal Investigator. Completed.

Tariman, J. D., "The role of the nurse in the era of cancer treatment shared decision-making

process" Sponsored by Chicago Chapter Oncology Nursing Society, Private, $3,000.

(September 2014-October 2016).

Role: Principal Investigator. Completed.

Tariman, J.D., "QOL post-ASCT among elderly adults with multiple myeloma. Chicago

Oncology Nursing Society Research Grant, October 2002 to October 2005, ($1,500

Co-Principal Investigator with Judith Paice, PhD, FAAN, RN). Completed.

NIH Grant Proposal (Not funded)

NIH-NCI K23 CA201596-01. Characterization of Novel Inflammatory and Metabolic

Biomarkers of Cancer-Related Fatigue Using Proteomics and Genomics. Funds requested:

$303,000.00. Panel review released on June 25, 2015. Not funded.

Mentors: Dr. Leonard Jason and Dr. Judith Payne

PUBLICATIONS


Note: The symbol * denotes DePaul graduate student or DePaul faculty co-authors. ^denotes NorthShore

University School of Nurse Anesthesia faculty. First authorship and co-authorship are based on ICJME

guidelines on authorship.

Peer-Reviewed Original Research or Data-Based Papers (N=19):

*Allen, L., Tariman, J. D., & Simonovich, S. D. (accept with revision on August 10, 2020).

The Efficacy of a Web-Based, Educational Quality Improvement Project on Hand Hygiene

to Reduce Post-Cesarean Birth Surgical Site Infection. Journal of Nursing Practice and Review of Research,

*Holyszko, A., *Levin, L., ^Feczko, J., ^Krawczyk, S., Tariman, J. D. (accepted for publication

spring 2021). 5 for 25: How to prevent endotracheal tube cuff over-inflation. Journal of the

American Association of Nurse Anesthetists.

*Smith, L., *Iqbal, S., ^Krawczyk, S., & Tariman, J. D. (accepted for publication summer 2021).

Cultural competence in student registered nurse anesthetists in Illinois. Journal of the American

Association of Nurse Anesthetists. Accepted for publication.

*Nigro, T. M., ^Schwartz, P. S., ^Roche, B. T., & Tariman, J. D. (2020). A Comprehensive

Reentry Policy for Student Registered Nurse Anesthetists with Substance Use Disorder. Journal of

the American Association of Nurse Anesthetists, 88(4), 319-323.

*Warzyniec, A., Tariman, J. D., & *Simonovich, S. (2019). Shared decision making: Effects of an

online education session on knowledge, attitudes, adaptability, and communication skills among

nurses. Clinical Journal of Oncology Nursing, 23(6), 99. doi:10.1188/19.CJON.E93-E99

Tariman, J.D., *Katz, P., *Bishop-Royse, J., Hartle, L., Szubski, K. L., Enecio, T., et al. (2018).

Role competency scale on shared decision-making nurses: Development and psychometric

properties. SAGE Open Medicine, 6, 2050312118807614. doi: 10.1177/2050312118807614

*Wilson, C.K, Tariman, J.D., & *Graf, R. (2018). Online palliative care education in the skilled

nursing facility. Journal of Nursing Practice and Review of Research, 8(2), 13-26.

*Coletto, K., Tariman, J. D., *Lee, Y., & ^Kapanke, K. (2018). Perceived knowledge and attitudes

of Certified Registered Nurse Anesthetists and Student Registered Nurse Anesthetists on fire risk

assessments during time-out in the operating room. American Association of Nurse Anesthetists,

86(2), 99-108.

*Weaver, C., & Tariman, J. D. (2017). Multiple myeloma genomics: A systematic review.

Seminars in Oncology Nursing, 33(3), 237–253. Retrieved from

http://www.sciencedirect.com/science/article/pii/S0749208117300360

*Talbott, C., Watson, L., Tariman, J. D., & *Sorenson, M. (2016). "Clinical Chatter": Every nurse

informed. Journal of Clinical Nursing, 26(2017), 1301–1312. Retrieved from

http://dx.doi.org/10.1111/jocn.13620

Tariman, J.D., Gleason, C., Faiman, B., Doss, D., Catamero, D., *Bishop-Royse, J., ... Lonial, S.

(2016). Lack of health maintenance examinations and risk in myeloma patients. Cancer Medicine,

5(7), 1425–1435. doi:10.1002/cam4.716

Tariman, J.D., *Mehmeti, E., *Spawn, N., *McCarter, S., *Bishop-Royse, J., Garcia, I., ... Szubski,

K. (2016). Oncology nursing and shared decision-making for cancer treatment. Clinical Journal of

Oncology Nursing, 20(5), 560-563.

http://dx.doi.org/10.1111/jocn.13620


*McCarter, S.P., Tariman, J.D., *Spawn, N., *Mehmeti, E., *Bishop-Royse, J., Garcia, I., …

Szubski,K. (2016). Barriers & promoters to participation in the era of shared decision-making

process. Western Journal of Nursing Research, 38(10), 1282-97. doi: 10.1177/0193945916650648.

Epub 2016 May 18.

Tariman, J. D., Doorenbos, A., Schepp, K. G., Singhal, S., & Berry, D. L. (2015). Top information

need priorities of older adults newly diagnosed with active myeloma. Journal of the Advanced

Practitioner in Oncology, 6(1), 14-21.

Tariman, J. D., Doorenbos, A., Schepp, K. G., Becker, P., & Berry, D. L. (2014). Patient, physician

and contextual factors are influential in the treatment decision making of older adults newly

diagnosed with symptomatic myeloma. Cancer Treatment Communications, 2(2-3), 34-47. DOI:

http://dx.doi.org/10.1016/j.ctrc.2014.08.003

Tariman, J. D., Doorenbos, A., Schepp, K. G., Singhal, S., & Berry, D. L. (2014). Older adults

newly diagnosed with symptomatic myeloma and treatment decision making. Oncology Nursing

Forum, 41(4), 411-19.

Tariman, J. D., Doorenbos, A., Schepp, K. G., Singhal, S., & Berry, D. L. (2014). Information

needs priorities in patients diagnosed with cancer: A systematic review. Journal of the Advanced

Practitioner in Oncology, 2014(5), 115-22.

Heuck, C. J., Mehta, J., Bhagat, T., Gundabolu, K, Yu, Y., Khan, S., Chrysofakis, G., Schinke, C.,

Tariman J., et al (2013). Myeloma is characterized by stage-specific alterations in DNA

methylation that occur early during myelomagenesis. Journal of Immunology, 190(6), 2966-75. doi:

10.4049/jimmunol.1202493.

Faiman, B., Miceli, T. S., Richards, T., Tariman, J. D. (2012). Survey of experiences of an e-

mentorship program: Part II. Clinical Journal of Oncology Nursing, 16(1), 50-54.

Tariman, J. D., Berry, D. L., Halpenny, B., Wolpin, S., & Schepp, K. (2011). Validation and testing

of the Acceptability E-scale for web-based patient reported outcomes in cancer care. Journal of

Applied Nursing Research, 24(1), 53-58.

Tariman, J. D., Berry, D. L., Cochrane, B., Doorenbos, A., Schepp, K. (2010). Preferred and actual

level of participation during health care decision-making in persons with cancer: A systematic

review. Annals of Oncology, 21(6), 1145-51.

Rehwaldt, M., Wickham, R., Purl, S., Tariman, J., Blendowski, C., Shott, S., et al. (2009). Self-care

strategies to cope with taste changes after chemotherapy. Oncology Nursing Forum, 36(2), E47-56.

Chanan-Khan, A.A., Kaufman, J.L., Mehta, J., Richardson, P.G., Miller, K.C., Lonial, S., Munshi, N.

C., Schlossman, R. Tariman, J., et al., (2007). Activity and safety of bortezomib in multiple

myeloma patients with advanced renal failure: A multicenter retrospective study. Blood, 109(6),

2604-06.

Peer-Reviewed, Professional Journal Review Articles (N=39)

http://dx.doi.org/10.1016/j.ctrc.2014.08.003http://www.ncbi.nlm.nih.gov/pubmed?term=Heuck%20CJ%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Mehta%20J%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Bhagat%20T%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Gundabolu%20K%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Yu%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Khan%20S%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Chrysofakis%20G%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Schinke%20C%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed?term=Tariman%20J%5BAuthor%5D&cauthor=true&cauthor_uid=23408834http://www.ncbi.nlm.nih.gov/pubmed/19273394?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumhttp://www.ncbi.nlm.nih.gov/pubmed/19273394?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum


Tariman, J. D., *Tarvainis, A., Webber-Ritchey-K., Simonovich, S. D. (2020). Shared decision-

making competency: Provider-specific factors in hematology-oncology practice. Clinical Journl

of Oncology Nursing, 24(4), 346-351. doi: 10.1188/20.CJON.346-351

*LaPenna, D., & Tariman, J. D. (2020). Art Therapy: A Literature Review of Efficacy in

Improving Psychosomatic Symptoms in Patients With Cancer. Clinical journal of oncology

nursing, 24(2), 123–126. https://doi.org/10.1188/20.CJON.123-126

*Stanciu, J., & Tariman, J. D. (2020). Liquid biopsy: A tool for the diagnostic and prognostic

evaluation of Cancers. Clinical Journal of Oncology Nursing, 24(1), 19-21.

doi:10.1188/20.CJON.19-21

Negrete, T.N., & Tariman, J.D. (2019). Pediatric palliative care: A literature review of best

practices in oncology nursing education programs. Clinical Journal of Oncology Nursing, 23(6),

565-568. doi:10.1188/19.CJON.565-568

Faiman, B., & Tariman, J.D. (2019). Shared decision making: Improving patient outcomes by

understanding the benefits of and the barriers to effective communication. Clinical Journal of

Oncology Nursing, 23(5), 540-542. doi: 10.1188/19.CJON.540-542.

Woods, T., Tariman, J.D., & Lee, Y.M. (2019). Enteral and parenteral nutrition: An integrative

literature review on nutrition for recipients of pediatric hematopoietic stem cell transplantation.

Clinical Journal of Oncology Nursing, 23(4). 351-354. doi: 10.1188/19.CJON.351-354.

Tariman, J.D. (2018). Biosimilars: Exploring the history, science, and progress. Clinical Journal

of Oncology Nursing, 22(5), 5-12. doi: 10.1188/18.CJON.S1.5-12

*Malibiran, R., Tariman, J.D., & *Amer, K. (2018). Bibliotherapy: Appraisal of evidence for

patients diagnosed with cancer. Clinical Journal of Oncology Nursing, 22(4), 377-380.

*Clayton, W.M., & Tariman, J.D. (2018). The nurse’s role in addressing barriers to cancer

screening in African Americans: An integrative literature review. Journal of Nursing Practice

and Review of Research, 8(1), 53-64.

*Pedersen, C., & Tariman, J.D. (2018). Beliefs and attitudes of American nurses on physician

assisted suicide: An integrative literature review. Journal of Nursing Practice and Review of

Research, 8(1), 24-38.

*Kojovic, B., & Tariman, J. D. (2017). Decision aids: Assisting patients with multiple myeloma

and caregivers with treatment decision making. Clinical Journal of Oncology Nursing, 21(6),

660–664. https://doi.org/10.1188/17.CJON.660-664

*Houlihan, M.C., & Tariman, J.D. (2017). Comparison of outcome measures for traditional and

online support groups for breast cancer patients: An integrative literature review. Journal of the

Advanced Practitioner in Oncology, 8, 348-359

Rome, S., Noonan, K., Bertolotti, P., Tariman, J. D., & Miceli, T. (2017). Bone health, pain, and

mobility: Evidence-based recommendations for patients with multiple myeloma. Clinical Journal

of Oncology Nursing, 21(5), 47–59. Retrieved from https://cjon.ons.org/content/about-cjon

Brigle, K., Pierre, A., Finley-Oliver, B., Faiman, B., Tariman, J. D., & Miceli, T. (2017).

Myelosuppression, bone disease, and acute renal failure: Evidence-based recommendations for


oncologic emergencies. Clinical Journal of Oncology Nursing, 21(5), 60–76. Retrieved from

https://cjon.ons.org/content/about-cjon

Faiman, B., Doss, D., Colson, K., Mangan, P., King, T., & Tariman, J. D. (2017). Renal, GI, and

peripheral nerves: Evidence-based recommendations for the management of symptoms and care

for patients with multiple myeloma. Clinical Journal of Oncology Nursing, 21(5), 19–36.

Retrieved from https://cjon.ons.org/content/about-cjon

*Oliveira, C., & Tariman, J. (2017). Barriers to patient advocacy role: An integrative review of

the literature. Journal of Nursing Practice and Review of Research, 7(2), 7–12. Doi

http://www.mypnaa.org/JNPARR/Publications-Vol-7-Issue-2

*Mallari, M. G., & Tariman, J. D. (2017). Ethical framework for decision making in nursing

practice and research. Journal of Nursing Practice and Review of Research, 7(1), 50–57. Doi

http://www.mypnaa.org/JNPARR/Publications-Vol-7-Issue-1

Tariman, J.D. (2017). Changes in cancer treatment: Mabs, mibs, mids, nabs and nibs. Nursing

Clinics of North America, 52(1), 65-81.

Tariman, J.D., & GDhorajiwala, S. (2016). Genomic variants associated with cancer-related

fatigue: A systematic review. Clinical Journal of Oncology Nursing, 20(5), 537-546.

doi:10.1188/16.CJON.560-563

Kurtin, S., Colson, K., Tariman, J. D., Faiman, B, Finley-Oliver, E., & The IMF Nurse

Leadership Board. (2016). Adherence, persistence, and treatment fatigue in multiple myeloma.

Journal of the Advanced Practitioner in Oncology, 7(Suppl1), 71-77. doi:

10.6004/jadpro.2016.7.2.16

*Masterton, K.J., & Tariman, J. D. (2016). Effective transitional therapy for adolescent and

young adult cancer patients: An integrative literature review. Clinical Journal of Oncology

Nursing, 20(4), 391-396.

*Lee, Y.-M., *Florez, E. A., Tariman, J. D., *McCarter, S., Riesche, L. (2015). Factors related

to sexual behaviors and sexual education programs for Asian-American adolescents. Applied

Nursing Research, 28, 222-228.

Tariman, J. D., & Szubski, K. (2015). The evolving role of the nurse during cancer treatment

decision making process: A literature review. Clinical Journal of Oncology Nursing, 19(5), 548-

56.

Tariman, J. D., Berry, D. L., Cochrane, B., Doorenbos, A., & Schepp, K. G. (2012). Physician,

patient, and contextual factors affecting treatment decisions in older adults with cancer and

models of decision making: A literature review. Oncology Nursing Forum, 39(1), E70-E83.

Miceli, T. S., Colson, K., Faiman, B. M., Miller, K., Tariman, J. D., & the IMF Nurse

Leadership Board. (2011). Maintaining bone health in patients with multiple myeloma:

Survivorship care plan of the IMF Nurse Leadership Board. Clinical Journal of Oncology

Nursing, 15(Suppl), 9-23.

Bilotti, E., Faiman, B. M., Richards, T. A., Tariman, J. D., Miceli, T. S., Rome, S. I., & the IMF

Nurse Leadership Board. (2011). Survivorship care guidelines for patients living with multiple

https://cjon.ons.org/content/about-cjonhttp://www.mypnaa.org/JNPARR/Publications-Vol-7-Issue-2http://www.mypnaa.org/JNPARR/Publications-Vol-7-Issue-1


myeloma: Consensus statements of the IMF Nurse Leadership Board. Clinical Journal of

Oncology Nursing, 15(Suppl), 5-8.

Faiman, B. M., Mangan, P., Spong, J., Tariman, J. D., & the IMF Nurse Leadership Board.

(2011). Renal complications in multiple myeloma and related disorders: Survivorship care plan of

the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 15(Suppl), 66-76.

Colson, K., Doss, D.S., Swift, R., & Tariman, J. (2008). Expanding role of bortezomib in

multiple myeloma: Nursing implications. Cancer Nursing, 31(3), 239-49.

Tariman, J. D., Love, G., McCullagh, E. J., Sandifer, S., IMF Leadership Board. (2008).

Peripheral neuropathy associated with novel therapies in patients with multiple myeloma:

Consensus statement of the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing,

12(3, Suppl), 29-35.

Bertolotti, P., Bilotti, E., Colson, K., Curran, K., Doss, D., Faiman, B., the IMF Nurse

Leadership Board. (2008). Management of side effects of novel therapies for multiple myeloma.

Clinical Journal of Oncology Nursing, 12(3, Suppl), 9-12.

Faiman, B., Bilotti, E., Mangan, P.A., Rogers, K., & the IMF Nurse Leadership Board. (2008).

Steroid-associated side effects in patients with multiple myeloma: Consensus statement of the

IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 12(3, Suppl), 53-62.

Miceli, T., Colson, K., Gavino, M., Lilleby, K., & the IMF Nurse Leadership Board. (2008).

Myelosuppression associated with novel therapies in patients with multiple myeloma: Consensus

statement of the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 12(3,

Suppl), 13-19.

Rome, S., Doss, D.S., Miller, K., Westphal, J., & the IMF Nurse Leadership Board. (2008).

Thromboembolic events associated with novel therapies in patients with multiple myeloma:


12(3, Suppl), 21-27.

Smith, L.C., Bertolotti, P., Curran, K., Jenkins, B., & the IMF Nurse Leadership Board. (2008).

Gastrointestinal side effects associated with novel therapies in patients with multiple myeloma:


12(3, Suppl), 37-51.

Tariman, J. D. (2007). Lenalidomide: A promising novel agent for patients with relapsed and/or

refractory multiple myeloma. Clinical Journal of Oncology Nursing, 11, 569-74.

Rodriguez, A., Tariman, J.D., Enecio, T., Estrella, M. E. (2007). The role of high dose

chemotherapy supported by hematopoietic stem cell transplantation in patients with MM:

Implications for nursing. Clinical Journal of Oncology Nursing, 11, 579-89.

Tariman, J.D. (2007). Current therapies for multiple myeloma. Journal of Infusion Nursing,

30(2), 113-18.


Tariman, J.D. & Estrella, E. (2005). The changing treatment paradigm in patients with newly

diagnosed multiple myeloma: Implications to nursing practice. Oncology Nursing Forum, 31,

E127-E138.

Colson, K., Doss, D. S., Swift, R., Tariman, J., & Thomas, T. E. (2004). Bortezomib, a newly

approved proteasome inhibitor for the treatment of multiple myeloma: Nursing implications.

Clinical Journal of Oncology Nursing, 8(5), 473-80.

Tariman, J.D. (2004). Clinical applications of magnetic resonance imaging in patients with

multiple myeloma. Clinical Journal of Oncology Nursing, 8, 317-20.

Tariman, J.D. (2003). Understanding novel therapeutic agents for multiple myeloma. Clinical

Journal of Oncology Nursing, 7, 521-28.

Tariman, J.D. & Lemoine, C (2003). Bortezomib. Clinical Journal of Oncology Nursing, 7, 687-

89.

Tariman, J.D. (2003). Thalidomide: Current therapeutic uses and management of its toxicities.

Clinical Journal of Oncology Nursing, 7, 143-47.

Books (N=3)

Faiman, B., & Tari an, J. D.. (In press, 2021). Multiple Myeloma: A Textbook for Nurses (3rd

ed.). Pittsburgh, PA: Oncology Nursing Society Publishing Division.

Tariman, J. D. & Faiman, B. (2015). Multiple Myeloma: A Textbook for Nurses (2nd ed.).

Pittsburgh, PA: Oncology Nursing Society Publishing Division.

Tariman, J. D. (2010). Multiple myeloma: A textbook for nurses. Pittsburgh, PA: Oncology

Nursing Society Publishing Division.

Book chapters (N=9)

Kaufman, C., & Tariman, J.D. (Fall 2021- In Press). Life care planning: Oncology. AANLCP

Core Curriculum. Hoffman Estates, IL: American Association of Nurse Life Care Planners.

Tariman, J.D. & *Dolores, J. (2019). Chapter 21: Multiple myeloma. In. S. M. Mahon & R. Bell

(Eds.), Study guide for the core curriculum for oncology nursing (6th ed.). St. Louis, MO:

Elsevier, Inc.

*Katz, P., & Tariman, J.D. (2019). Chapter 6: Communication and shared decision-making. In.

S. M. Mahon & R. Bell (Eds.), Study guide for the core curriculum for oncology nursing (6th ed.).

St. Louis, MO: Elsevier, Inc.

Faiman, B., Richards, T., & Tariman, J. D. (2018). Chapter 62: Multiple myeloma. In C.H..

Yarbro, D. Wujcik, & B.H. Gobel (Eds.), Cancer nursing principles and practice (8th ed., pp.

6167–6324). Burlington, MA: Jones and Bartlett Learning, LLC.

Tariman, J.D., Faiman, B. (2015). Chapter 1: Introduction. In. J. D. Tariman & B. Faiman

(Eds.), Multiple myeloma: A textbook for nurses (2nd ed.). Pittsburgh, PA: ONS Publishing

Division.


Tariman, J.D. (2015). Chapter 12: Clinical trials. In. J. D. Tariman & B. Faiman (Eds.), Multiple

myeloma: A textbook for nurses (2nd ed.). Pittsburgh, PA: ONS Publishing Division.

Tariman, J. D. & Faiman, B. (2011). Chapter 61: Multiple myeloma. In. C.H. Yarbro, M.H.

Frogge, & M. Goodman, Cancer nursing principles and practice (7th ed., pp. 1513-1545).

Sudbury, MA: Jones and Bartlett Publishers.

Tariman, J. D. (2010). Chapter 1: Introduction. In. J. D. Tariman (Ed.), Multiple myeloma: A

textbook for nurses (pp. 1-7). Pittsburgh, PA: ONS Publishing Division.

Tariman, J. D. (2010). Chapter 14: On the horizons: Future considérations. In. J. D. Tariman

(Ed.). Multiple myeloma: A textbook for nurses (pp. 267-277). Pittsburgh, PA: ONS Publishing

Division.

Tariman, J. D. (2005). Chapter 59: Multiple myeloma. In. C.H. Yarbro, M.H. Frogge, & M.

Goodman, Cancer nursing principles and practice (6th ed., pp. 1460-1489). Sudbury, MA: Jones

and Bartlett Publishers.

Doctoral Dissertation

Tariman, J.D. (2011). Treatment Decision Making in Older Adults Newly Diagnosed with

Myeloma. University of Washington, Ph.D. (180 p) (doctoral dissertation - research) ISBN: 978-

1-124-60389-6.

Refereed Published Abstracts (N=22):

Faiman, B., King, T., Manchulenko, C., Noonan, K., Gleason, C., & Tariman, J. (2019).

Development of a participatory patient decision aid for patients with multiple myeloma. Clinical

Lymphoma, Myeloma and Leukemia: Supplement, 19(10), 349. doi:10.1016/j.clml.2019.09.575

*Bilanicz, S., & Tariman, J.D. (2018). Teaching links between epigenetics and anesthesia to

anesthesia providers. 42nd Annual MNRS Research Conference. Cleveland, OH. March 2018

Faiman, B., Moran, D., Gleason, C., Richards, T., Catamero, D., King, T., . . . Tariman, J. (2017).

Symptom management and adherence in multiple myeloma (mm): A plan to disseminate best-

practice guidelines for nurses. Clinical Lymphoma Myeloma and Leukemia: Supplement, 17(1),

160. doi:10.1016/j.clml.2017.03.291

Tariman, J., & *Kojovic, B. (2017). Decision aids utilized by patients and clinicians during

treatment decision making for multiple myeloma: An integrative literature review. Clinical

Lymphoma Myeloma and Leukemia, 17(1, Supp), e159.

Tariman, J., & *Cluster, A. (2017). Common adverse effects of novel therapies for multiple

myeloma and their management strategies: A need for clinical research priority (oral

presentation). Clinical Lymphoma Myeloma and Leukemia, 17(1, Supp), e156.

Tariman, J., Vahey-Marcello, K., Huff, C., Kumar, S., Vinther, A., Bowser, A., . . . Obholz, K.

(2016). Using continuing medical education to promote shared decision-making in patients


diagnosed with multiple myeloma. Blood, 128(22), 2388-2388.

doi:10.1182/blood.V128.22.2388.2388

Tariman, J. (2015). Integrating myeloma genomics into nursing practice: Patient education and

shared decision making. Clinical Lymphoma Myeloma and Leukemia, 15(Supp 3), e316-e317.

Tariman, J. D. (2013). Treatment, prognosis and self-care are top information need priorities of

older adults newly diagnosed with active Myeloma (Abstract # 352). Clinical Lymphoma,

Myeloma & Leukemia, 13(1Suppl), 26.

Tariman, J. D. (2013). Older adults newly diagnosed with myeloma want to participate in

treatment decision making (Abstract # 351). Clinical Lymphoma, Myeloma & Leukemia,

13(1Suppl), 26.

Faiman, B., Tariman, J., Bilotti, E., Doss, D., Miller, K, Richards, T., Gleason, C. and The

International Myeloma Foundation Nurse Leadership Board. Health maintenance and preventive

care practices of myeloma survivors (Abstract #339). Clinical Lymphoma, Myeloma &

Leukemia, 13(1Suppl), 25.

Heuck, C., Mehta, J., Tariman, J., Pulliam, N., Yu, Y., Bhagat, T., et al. (2010). Epigenomic

profiling of multiple myeloma shows widespread stage specific alterations in DNA methylation

that occur early during myelomagenesis [Abstract #784]. Blood, 116(21), 344.

Tariman, J. D., Berry, D. L., Cochrane, B., Doorenbos, A., & Schepp, K. (2010). Treatment

decision-making in older adults newly diagnosed with myeloma: A Preliminary analysis.

Communicating Nursing Research (CD-ROM). Poster presentation at WIN Conference 2010.

Tariman, J. D. (2009). Preferred and actual level of participation during treatment decisions in

persons with cancer: A systematic review. Communicating Nursing Research (CD-ROM). Poster

presentation at Western Institute of Nursing Conference 2009.

Tariman, J. D. (2009). A proposed theoretical model of decision-making participation,

decisional conflict, regret, satisfaction, and QOL in adults with cancer. Communicating Nursing

Research (CD-ROM). Poster presentation at WIN Conference 2009.

Moran, D., Bertolotti, P., Bilotti, E., Colson, K., Curran, K., Doss, D., Faiman, B., Tariman, J.

D., et al. (2009). Long-term care guidelines for myeloma patients [Abstract # 30]. Clinical

Lymphoma & Myeloma, 9, S6-S7.

Tariman, J. D. (2008). Decision-making in oncology settings: A concept analysis.

Communicating Nursing Research, 41, 336.

Tariman, J.D., Berry, D.L., Halpenny, B., & Wolpin, S. (2008). Validation and testing of the

Acceptability E-scale. Communicating Nursing Research, 41, 372.

Bertolotti, P., Bilotti, E., Colson, K., Curran, K., Doss, D., Faiman, B., Tariman, J. D., et al.

(2007). Nursing guidelines for enhanced patient care [Abstract # PO-1102]. Haematologica,

92(6Suppl), 211.


Tariman, J. D., Paice, J., Mehta, J., Duffey, S. & Singhal, S. (2007). Quality of life (QOL) in

older adults undergoing autologous stem cell transplant (ASCT) [Abstract No. 101]. Oncology

Nursing Forum, 34(1), 207.

Rehwaldt, M., Purl, S., Tariman, J. D., Blendowski, C., Lappe, M., Shott, S., & Wickman, R.

(2006). A study of taste change strategies [Abstract No. 256]. Oncology Nursing Forum, 33(2),

467.

Gidron, A., Tariman, J., Shabbir, M., Mehta, J., Singhal, S. (2005). High plasma cell labeling

index is an adverse prognostic factor in bortezomib-treated patients with relapsed myeloma

[Abstract No. 3471]. Blood, 106(11), 968A-969A.

Kut, V., Mehta, J., Tariman, J., Olsson, A., Singhal, S. (2004). Osteonecrosis of the jaw in

myeloma patients receiving pamidronate or zoledronate [Abstract No. 4933]. Blood, 104, 315b.

Singhal, S., Tariman, J., Smith, K., Riley, M.B., Mistina, J., Mehta, J. (2003). Bortezomib is

effective therapy for relapsed multiple myeloma [Abstract No. 5289]. Blood, 102(11), 390B-

391B.

Singhal, S., Goolsby, C., Taylor, R., Tariman, J., Karpus, W., Mehta, J. (2003). Identifying

novel therapeutic targets in myeloma: CD20, CD25 and CD52 expression on malignant plasma

cells [Abstract No. 5221]. Blood, 102(11), 373B-373B.

Tariman, J. D. (2003). Performance improvement for myelosuppressed patients: Institutional

case studies. In. D. Wujcik & C. Lemoine. Performance improvement in myelosuppression

management: Continuing the ATAQ initiatives. A monograph.

Columns and Editorial - During Five-year Term as Associate Editor for ONS Connect (2005-2010) and

Three-year term as Column Writer for Advanced for Nurse Practitioners (2006-2009) and Three-year

term as Associate Editor for CJON Supportive Care Column (2017-2020) [N=30]

Tariman, J. D. (2010). Role specialization in oncology: Finding your niche. ONS Connect,

25(5), 6-9.

Tariman, J. D. (2010). Where to draw the line: Professional boundaries in social networking.

ONS Connect, 25(2), 10-13.

Tariman, J. D. (2009). Promoting testicular health: Strategies that work. Advance for Nurse

Practitioners, 17(11), 18.

Tariman, J. D. (2009). Do you know how to care for older adults? ONS Connect, 24(12), 8-11.

Tariman, J. D. (2009). Mentoring in publication: A lifelong legacy. ONS Connect, 24(1), 8-12.

Tariman, J. D. (2009). Men and Alzheimer’s disease: Sex differences in risk. Advance for Nurse


http://scholar.google.com/scholar?cluster=4654371527048978471&hl=en&oi=scholarrhttp://scholar.google.com/scholar?cluster=4654371527048978471&hl=en&oi=scholarr


Lowe, J. & Tariman, J. D. (2008). Lower extremity amputation: Black men with diabetes

overburdened. Advance for Nurse Practitioners, 16(11), 28.

Tariman, J. D. (2008). Suicide among boys and men: More challenges ahead. Advance for Nurse


Tariman, J. D. (2008). Technologic advancements in cancer care: Changing practice, changing

patients' lives. ONS Connect, 23(7), 8-11.

Tariman, J. D. (2008). Life span vs. healthy life expectancy: Where did men go wrong? Advance

for Nurse Practitioners, 16(5), 26.

Tariman, J. D. (2008). Obesity in men. Advance for Nurse Practitioners, 16(2), 26.

Tariman, J. D. (2007). Subfertility in men. Advance for Nurse Practitioners, 15(11), 25.

Tariman, J. D. (2007). Osteoporosis in men: A real threat. Advance for Nurse Practitioners,

15(8), 21.

Tariman, J. D. (2007). Testosterone replacement. Advance for Nurse Practitioners, 15(2), 22.

Tariman, J. D. (2007). Understand substance abuse in nurses. ONS Connect, 22(8), 18.

Tariman, J. D. (2007). Straight talk. When should you blow the whistle for ethical reasons? ONS

Connect, 22(2), 22-23.

Tariman, J. D. (2007). Exploring an unfamiliar world: Advice for novices delving into the

research arena. ONS Connect, 22(12), 12-16.

Tariman, J. D. (2007). Emergency preparedness: What have we learned? ONS Connect, 22(9),

8-12.

Tariman, J. D. (2007). Diabetes in minority men. Advance for Nurse Practitioners, 15(2), 18.

Tariman, J. D. (2006). Is your chapter on the road to success or experiencing some bumps along

the way? ONS News, 21(12), 1, 4-5.

Tariman, J. D. (2006). ONS members bring oncology nursing-sensitive patient outcomes to the

bedside. ONS News, 21(10), 1, 4-6.

Tariman, J. D. (2006). Prostate cancer: Screening and early detection. Advance for Nurse


Tariman, J. D. (2006). Smoking cessation in men. Advance for Nurse Practitioners, 14(6), 21.

Tariman, J. D. (2006). Substance abuse among adolescent boys. Advance for Nurse



Berenson, J., Tariman, J. D., Bensinger, W., Doss, D., & Swift, R. A. (2004). ONS News:

Spotlight on Symposia, 19(9), 79-80.

Tariman, J. D. (2003). Performance improvement for myelosuppressed patients: Institutional

case studies. In. D. Wujcik & C. Lemoine. Performance improvement in myelosuppression

management: Continuing the ATAQ initiatives. Pittsburgh, PA: Oncology Nursing Society. P33-

37.

Tariman, J. & Hammer, M. (2009). The PSONS research survey results. Puget Sound Oncology

Nursing Society Quarterly, 32(2), 11, 13-14.

Tariman, J. D. (2008). Multiple myeloma: Maximizing the therapeutic benefits of every novel

agent. Puget Sound Oncology Nursing Society Quarterly, 31(3), 1, 3-5.

Tariman, J. D. (2003). Clinical Update: Thalidomide in patients with multiple myeloma.

Chicago Chapter Oncology Nursing Society Newsletter, Lead article, Fall 2003.

Tariman, J. D. (2003). IMiDs: Novel thalidomide analogue for multiple myeloma. Chicago

Chapter Oncology Nursing Society Newsletter, Lead article, Summer 2003

SCHOLARLY PAPERS PRESENTED

International Oral Presentation (N=3)

Tariman, J.D., & *Weaver, C.J. (2015). 15th International Myeloma Workshop and 2nd

Myeloma Nursing Symposium. Plenary Session Lecture. Topic: Integrating Myeloma Genomics

into Nursing Practice: Patient Education and Shared Decision Making. Rome, Italy. Presented on

September 23, 2015.

Tariman, J.D. (2015). 15th International Myeloma Workshop and 2nd Myeloma Nursing

Symposium. Abstract Session, Oral Presentation. Topic: Lack of health maintenance and risks:

An Internet-based survey on health maintenance and preventive care patterns in patients with

myeloma. Rome, Italy. Presented on September 23, 2015.

Tariman, J.D. & Berry, D., Halpenny, B. (2008). International Society of Nurses in Cancer Care

(ISNCC) Biennial Conference. Oral Session: Computerized Assessment for Patients with Cancer:

aka Electronic Self Report Assessment-Cancer (ESRA-C). Singapore City, Singapore; August

2008.

International Poster Presentation (N=12)

Tariman, J.D., *Adams, K., *Guerrieri, L., *Bishop-Royse, J. (2018). Lack of racial diversity in

multiple myeloma drug trials participation: A systematic review (Abstract #11252). The

European Society of Hematology (ESH) 4th International Conference on Multiple Myeloma.

October 5, 2018. Mandelieu, France.


*Katz, P., Tariman, J.D., Hartle, L., Szubski, K. (2017). Development and testing of cancer

treatment shared decision-making scale for nurses (SDMS-N) [Abstract #203]. 28th International

Nursing Research Congress of the STTI Honor Society of Nursing. Poster Session: Dublin,

Ireland; July 28, 2017.

*Ross, E., Tariman, J.D., *Bishop-Royse, J., (2017).Psychological and psychosocial deficits

among pediatric survivors of hematological neoplasms and their risk factors [Abstract #208]. 28th

International Nursing Research Congress of the STTI Honor Society of Nursing. Poster Session:

Dublin, Ireland; July 28, 2017.

Tariman, J., & *Cluster, A. (2017). Common adverse effects of novel therapies for multiple

myeloma (MM) and their management strategies: A need for clinical research priority [Abstract

#278]. 16th International Myeloma Workshop. New Delhi, India. Presented on March 4, 2017.

Tariman, J., & *Kojovic, B. (2017). Decision aids utilized by patients and clinicians during

treatment decision making for multiple myeloma: An integrative review [Abstract #285]. 16th

International Myeloma Workshop. New Delhi, India. Presented on March 4, 2017.

Faiman, B., Moran, D., Gleason, C., Richards, T., Catamero, D., King, T., … Tariman, J.D.

(2017). Symptom management and adherence in multiple myeloma (MM): A plan to disseminate

best practice guidelines for nurses. 16th International Myeloma Workshop. New Delhi, India.

Presented on March 4, 2017.

*McCarter, S., Tariman, J.D., *Spawn, N., & *Mehmeti, E. (2015). 26th International Nursing

Research Congress of the STTI Honor Society of Nursing. Poster Session: Barriers and Promoters

for Nurses Participation in Cancer Treatment Decision Making Process and Patient Satisfaction

with Treatment Decision. San Juan, Puerto Rico. Presented on July 24, 2015.

Tariman, J.D. (2013). XIV International Myeloma Workshop. Poster Session: Treatment,

prognosis and self-care are top information need priorities of older adults newly diagnosed with

active Myeloma. Kyoto, Japan; April 2013.

Tariman, J.D. (2013). XIV International Myeloma Workshop. Poster Session: Older adults

newly diagnosed with myeloma want to participate in treatment decision making. Kyoto, Japan;

April 2013.

Tariman, J.D. (2011). XIII International Myeloma Workshop. Poster Session: International

Myeloma Foundation Nurse Leadership Guidelines for the Management of Common Side Effects

from Novel Agents for Myeloma. Paris, France; May 2011.

Tariman, J.D. (2007). XI International Myeloma Workshop - Nursing guidelines for enhanced

patient care. Poster Session, XI International Myeloma Workshop. Kos, Greece; June 2007.

Tariman, J.D. (2005). IX International Myeloma Workshop - The Cleveland Clinic Nursing

Symposium – Management of Chemotherapeutic Side Effects, Sydney, Australia; April 2005.

USA National Lectures (N=29)


Tariman, J.D., Faiman, B. Noonan, K., & Rome, S. (2019). Case studies for nurses: Evolution in

myeloma treatment. 44th Annual Oncology Nursing Society Congress 2019 Co-chair and

presenter. Anaheim, CA. To be presented on April 11, 2019.

Tariman, J.D. (2018). Medscape’s Clinical Updates on CLL. 43rd Annual Oncology Nursing

Society Congress. Presenter. Boston, MA. Presented on May 18, 2018.

Tariman, J.D., Faiman, B. Mangan, P., & Brigle, K. (2018). Case studies in multiple myeloma:

Best practices in patient care and symptom management. 43rd Annual Oncology Nursing Society

Congress 2018 Co-chair and presenter. Washington, D.C. Presented on May 17, 2018.

Tariman, J.D. (2018). Communication needs of older adults with cancer. 43rd Annual Oncology

Nursing Society Congress 2018 Presenter. Washington, D.C. Presented on May 18, 2018.

Tariman, J.D. (2018). Best practices in multiple myeloma summit. 2018 Academy of Oncology

Nurse Navigators (AONN) National Conference Presenter. Boston, MA. Presented on May 4,

2018.

Tariman, J.D., & Faiman, B. (2017). Case studies in multiple myeloma: Best practices in patient

care and symptom management for nurses. 42nd Annual Oncology Nursing Society Congress

2017 Co-chair and presenter. Hyatt Regency, Denver, CO. Presented on May 4, 2017.

Tariman, J.D. (2016). The role of the nurse in the era of shared decision making for patients

diagnosed with myeloma. 36th Annual Philippines Nurses Association of America Convention

Presenter. Washington, D.C. presented on July 22, 2016.

Tariman, J.D., Faiman, B., Catamero, D., & Richards, T. (2016). Updates in multiple myeloma:

Case studies in collaborative nursing and patient care. 41st Annual Oncology Nursing Society

Congress 2016 Co-chair and presenter. Marriott Riverside San Antonio, TX. Presented on April

28, 2016.

Tariman, J.D. (2015). Advocacy in action: Implementing shared decision making in multiple

myeloma. 40th Annual Oncology Nursing Society Congress 2015 Chair and presenter. Hyatt

Regency, Orlando, FL. Presented on April 23, 2015.

Tariman, J.D., Faiman, B., Miceli, T., & Kurtin, S. (2015). Case studies in myeloma: Nursing

implications of evolving treatment paradigms. 40th Annual Oncology Nursing Society Congress

2015 Co-chair and presenter. Orange County Convention Center, Florida. Presented on April 23,

2015.

Tariman, J.D., Faiman, B., Bertolotti, P., & Kurtin, S. (2014). Case studies in multiple myeloma

treatment: Best practices for nurses. 39th Annual Oncology Nursing Society Congress 2014 Co-

chair and presenter. Anaheim, CA. Presented on May 1, 2014.

Tariman, J.D., Faiman, B., Kurtin, S., & Gleason, C. (2013). New paradigms in multiple

myeloma management: Nurse-centric case studies in survivorship. 38th Annual Oncology Nursing

Society Congress 2013 Chair and presenter. Washington, D.C. Presented on April 25, 2013.


Tariman, J.D., Faiman, B, Miceli, T., & Tiffany, R. (2012). Multiple myeloma: The patient

journey through survivorship. 37th Annual Oncology Nursing Society Congress 2012 Chair and

presenter. New Orleans, LA. Presented on May 3, 2012.

Faiman, B., Bilotti, E., Colson, K., & Tariman, J.D. (2011). Long-term survivorship care

guidelines for multiple myeloma patients. 36th Annual Oncology Nursing Society Congress 2011

Presenter. Boston, MA. Presented on April 28, 2011.

Tariman, J.D. (2010). Survivorship care issues in patients with myeloma: Safety and mobility.

Oncology Nursing Society Institute of Learning Fall Conference Presenter. Tampa, FL. Presented

on November 7, 2010.

Bilotti, E, Faiman, B., Miceli, T., Richards, T., & Tariman, J.D. (2010). Changing patient care in

multiple myeloma: The International Myeloma Foundation Nurse Leadership Board’s long-term

survivorship care plan. 35th Annual Oncology Nursing Society Congress 2010 Presenter. San

Diego, CA. Presented on May 13, 2010.

Tariman, J.D. (2009). Navigating the clinical course of multiple myeloma patient care: Induction

therapies for transplant ineligible patients. 34th Annual Oncology Nursing Society Congress 2009

Presenter. San Antonio, TX. Presented on April 30, 2009.

Tariman, J.D. (2009). Management of treatment-related effects. 34th Annual Oncology Nursing

Society Congress 2009 Presenter. San Antonio, TX. Presented on April 29, 2009.

Tariman, J.D. (2009). Leading the way: Managing multiple myeloma for the long-term. Updates

on novel therapies. 34th Annual Oncology Nursing Society Congress 2009 Presenter. San

Antonio, TX. Presented on May 1, 2009.

Tariman, J.D. (2008). Changing paradigms in the treatment of multiple myeloma: A nurse-

centric case-based discussion. 33rd Annual Oncology Nursing Society Congress 2008 Chair and

Presenter. Philadelphia, PA. Presented on May 16, 2008.

Tariman, J.D. (2008). Staying upright: Managing spinal complications for patients with cancer.

33rd Annual Oncology Nursing Society Congress 2008 Presenter. Philadelphia, PA. Presented on

May 16, 2008.

Tariman, J.D. (2008). The IMF Nurse Leadership Board consensus of care: New insights on

novel therapies in multiple myeloma. 33rd Annual Oncology Nursing Society Congress 2008

Presenter. Philadelphia, PA. Presented on May 15, 2008.

Tariman, J.D. (2008). The spectrum of multiple myeloma patient care: A case-based assessment

for oncology nurses. ). 33rd Annual Oncology Nursing Society Congress 2008 Presenter.

Philadelphia, PA. May 17, 2008.

Mangan, P., Miceli, T.S., Rome, S., & Tariman, J.D. (2007). Management of side effects of

novel therapeutics: A nurse centric model. 32nd Annual Oncology Nursing Society Congress

Presenter. Las Vegas, NV. Presented on April 25, 2007.


Tariman, J.D. (2007). Updates on metastatic spine disorders. 32nd Annual Oncology Nursing

Society Congress Presenter. Las Vegas, NV. Presented in April 2007.

Tariman, J.D. (2005). Frontline therapies for multiple myeloma. 30th Annual Oncology Nursing

Society Congress 2005 Presenter. Orlando, FL. Presented in April 2005.

Tariman, J.D. (2004). Multiple myeloma: A new treatment paradigm. 29th Annual Oncology

Nursing Society Congress Presenter. Anaheim, CA. Presented in April 2004.

Tariman, J.D. (2003). Proteasome inhibition in multiple myeloma. Oncology Nursing Society

Fall Institute Presenter. Philadelphia, PA. Presented in November 2003.

Tariman, J.D. (2003). Bortezomib for relapsed and refractory multiple myeloma; 28th Annual

Oncology Nursing Society Congress Presenter. Denver, CO. Presented in April 2003.

Regional Conference Lectures (N=15)

Tariman, J.D. (2018). International Myeloma Foundation patient and family seminar: Living

well with myeloma. Presenter. Seattle, WA. May 2018

Tariman, J.D. (2015). International Myeloma Foundation's Nurse Leadership Board Annual

Meeting; Presenter. Development and psychometric testing of the IMF NLB myeloma-specific

health maintenance and preventive care questionnaire. Las Vegas, NV. August 2015

Tariman, J.D. (2014). International Myeloma Foundation's Nurse Leadership Board Annual

Meeting; Chair and Presenter. Health maintenance care pattern among myeloma patients.

Hollywood, CA. October 2014

Tariman, J.D. (2013). International Myeloma Foundation patient and family seminar: Quality of

life session on the management of chemotherapy side effects and survivorship care plan.

Presenter. Northbrook, IL. August 2013

Tariman, J.D. (2009). Plasma cell disorders: Annual Scripps Advanced Practice Nurses

Oncology Conference 2009 Presenter. San Diego, CA. Presented in February 2009.

Tariman, J.D. (2007). Advances in multiple myeloma: Annual Northwest Oncology Conference

2007. Presenter. Boise, ID. October 2007

Tariman, J.D. (2007). Novel therapies for patients with multiple myeloma and nursing

management of common toxicities. Annual Scripps Cancer Center Oncology Conference 2007.

Presenter. San Diego, CA. September 2007

Tariman, J.D. (2006). Myeloma: Disease overview, treatment considerations and nursing

implications. Florida Oncology Conference 2006. Presenter. Orlando, FL. January 2006

Tariman, J.D. (2005). Myeloma: Disease overview, treatment and clinical update on bortezomib

therapy. Midwest Oncology Conference 2005. Presenter. Milwaukee, WI. December 2005


Tariman, J.D. (2005). International Myeloma Foundation's Patient and Family Seminar: QOL

session. Presenter. Northbrook, IL. June 2005.

Tariman, J.D. (2005). Advances in multiple myeloma: Scripps’s Cancer Center 2005 Annual

Advanced Practice Nurse Conference. Presenter. San Diego, CA. March 2005

Tariman, J.D. (2004). Advances in hematologic malignancies: Cornell-NYU Letters & Science

2004 Annual Oncology Conference. Presenter. Manhattan City, NY. October 2004

Tariman, J.D. (2004). Novel agents for multiple myeloma. Northwestern Memorial Hospital’s

Annual Oncology Nursing Conference Program Chair and Presenter. Chicago, IL. October 2004

Tariman, J.D. (2004). Novel therapeutic options for myeloma. Annual Oncology Care

Conference 2004. Presenter. Honolulu, HI. July 2004

Tariman, J.D. (2003). Symptom management in patients with multiple myeloma. Chicago

Myeloma Symposium 2003. Presenter. Chicago, IL. September 2003

Online Educational Presentations (N=10)

Tariman, J.D., Huff, C.A., & Kumar, S. (2015). Advances in multiple myeloma care: Providing

optimal care and promoting shared decision making. Available at:

http://www.clinicaloptions.com/Oncology/Treatment%20Updates/Myeloma%20Advances.aspx

Faiman, B, Kurtin, S., & Tariman, J.D. (2015). The Nurse View: Best Practices in Multiple

Myeloma. Available at: http://www.medscape.org/viewarticle/846311

Christiansen, N., Bensinger, W., Colson, K., Harvey, R. D., Lonial, S., & Tariman, J. D. (2009).

Module 8: Building the best myeloma regimens: Is there a blueprint? Available at

http://www.questmeded.com/ce-

bin/owa/pkg_disclaimer_html.display?ip_mode=secure&ip_company_code=P4CC&ip_test_id=1

4504&ip_cookie=32248899

Tariman, J. D. & Harvey, R. D. (2009). Module 2: Clinical considerations and implications for

optimizing patient outcomes in multiple myeloma. Available at

http://www.clinicaloptions.com/Oncology/Management%20Series/Multiple%20Myeloma.aspx

Harvey, R. D & Tariman, J. D. (2009). Module 1: Mechanisms of action and clinical advances

in the treatment of multiple myeloma. Available at

http://www.clinicaloptions.com/Oncology/Management%20Series/Multiple%20Myeloma.aspx

Tariman, J. D., Harvey, R. D. & Colson, K. (2009). Module 6: Multiple myeloma:

Relapsed/refractory disease – care team considerations. Available at

http://www.questmeded.com/ce-

bin/owa/pkg_disclaimer_html.display?ip_cookie=31242293&ip_mode=secure&ip_test_id=14409

&ip_company_code=P4CC

Tariman, J. D. & Harvey, R. D. (2009). Module 4: Multiple myeloma induction and transplant

strategies – care team considerations. Available at http://www.questmeded.com/ce-

http://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_mode=secure&ip_company_code=P4CC&ip_test_id=14504&ip_cookie=32248899http://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_mode=secure&ip_company_code=P4CC&ip_test_id=14504&ip_cookie=32248899http://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_mode=secure&ip_company_code=P4CC&ip_test_id=14504&ip_cookie=32248899http://www.clinicaloptions.com/Oncology/Management%20Series/Multiple%20Myeloma.aspxhttp://www.clinicaloptions.com/Oncology/Management%20Series/Multiple%20Myeloma.aspxhttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242293&ip_mode=secure&ip_test_id=14409&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242293&ip_mode=secure&ip_test_id=14409&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242293&ip_mode=secure&ip_test_id=14409&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242245&ip_mode=secure&ip_test_id=13569&ip_company_code=P4CC




Tariman, J. D., Fonseca, R., & Colson, K. (2008). Changing paradigms in the treatment of

multiple myeloma: Nurse-centric case-based discussions. Available at

http://old.imeronline.com/315_mm/home.html

Lonial, S. & Tariman J. D. (2008). Clinical updates in the management of patients with multiple

myeloma case-based DVD. Available at

http://www.thecbce.com/onlineEdu_detail.aspx?act_id=258

Smith, L., Tariman, J. D., & Harvey, R. D. (2008). Module 2: Diagnosis and staging of multiple

myeloma (MM) and front-line therapy for the transplant-ineligible patient: Care team

considerations. Available at http://www.questmeded.com/ce-



Institutional Lectures (N=11)

Tariman, J.D. (2015). Medscape Oncology. Shared decision making: Nurse perspective. New

York, NY; August 2015

Tariman, J.D. (2008). Harborview Medical Center. Multiple myeloma: Maximizing the

therapeutic benefits of every novel agent. Seattle, WA; December 2008

Tariman, J.D. (2008). Fred Hutchinson Cancer Research Center & Seattle Cancer Care Alliance.

Symptom management and nurse’s Role in Patient Care. International Myeloma Foundation

Patient and Family Seminar. Seattle, WA; January 2008.

Tariman, J.D. (2007). Fred Hutchinson Cancer Research Center & Seattle Cancer Care Alliance.

Management of renal insufficiency in patients with multiple myeloma. Seattle, WA; January 2007

Tariman, J.D. (2007). Pacific Northwest Oncology Cancer Center. Vertebroplasty and

kyphoplasty in patients with metastatic bone disease. Olympia, WA; February 2007

Tariman, J.D. (2006). Fort Collins ONS Chapter. Multiple myeloma: Disease overview and

advances in therapy. Fort Collins, CO; June 2006

Tariman, J.D. (2006). Lutheran General Hospital. Nursing management of patients with multiple

myeloma. Park Ridge, IL; March 2006

Tariman, J.D. (2006). Kaiser-Permanente Oncology. Nursing management of patients with

multiple myeloma. Portland, OR; January 2006

Tariman, J.D. (2005). Palm Beach Myeloma Support Group. Advances in myeloma therapy.

Palm Beach, FL; May 2005

Tariman, J.D. (2004). University of Pittsburgh Medical Cancer Center. Proteasome inhibition: A

novel option for the treatment of myeloma. Pittsburgh, PA; June 2004

http://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242245&ip_mode=secure&ip_test_id=13569&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242245&ip_mode=secure&ip_test_id=13569&ip_company_code=P4CChttp://old.imeronline.com/315_mm/home.htmlhttp://www.thecbce.com/onlineEdu_detail.aspx?act_id=258http://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242277&ip_mode=secure&ip_test_id=13567&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242277&ip_mode=secure&ip_test_id=13567&ip_company_code=P4CChttp://www.questmeded.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=31242277&ip_mode=secure&ip_test_id=13567&ip_company_code=P4CC


Tariman, J.D. (2003). Waukesha Memorial Hospital. Multiple Myeloma: Overview and novel

therapeutic agents. Waukesha, WI; May 2003

HONORS AND AWARDS

2019 Excellence in Research Award (National)

PNAA, USA

Atlanta, GA

2019 Nursing Excellence in Research Award (Region)

PNAA North Central Region

Columbus, OH

2018 Distinguished Alumni Award: Graduate School

Cebu Doctors’ University, Philippines

2018 Quality Matters Award for Online Teaching

DePaul University, Chicago, IL

2016 Fellow American Academy of Nursing (FAAN)

Washington, D.C.

2016 Excellence in NSG Education, Practice &

Research UVCN 25th Year Class Reunion

Philippines

2016 Fellow, Advocacy Leadership Institute

American Society of Hematology

Washington, D.C.

2014 Outstanding Alumni Award

UV College of Nursing Alumni Association

of Class 1988

Chicago, IL

2013 Oncology Nursing Society

Outstanding Achievement for Oncology Nursing

Family/Patient Education

Pittsburgh, PA

2012 Nurse of the Year

Leukemia Research Foundation

Chicago, Illinois

2011 Honored Nurse of the Year

Leukemia Lymphoma Society – Chicago

Chapter

2010 Outstanding Alumnus


University of the Visayas

College of Nursing, Philippines

2008 Best Student Poster Award

2008 Western Institute of Nursing

Conference

Garden Grove, CA USA

2007 Best Poster Award

National Cancer Nursing Research

Conference

Hollywood, CA USA

2006 Research Fellowship Award

Achievement Rewards for College Scientists

Seattle, WA

2006 Betty Irene and Gordon Moore Awardee

University of California San Francisco

San Francisco, CA USA

2005 Outstanding New Member Award

Oncology Nursing Society (ONS)

Chicago Chapter

Chicago, IL USA

1991 Academic Excellence Award

13th Place, National Registered Nurses Board

Examination

Philippines Board of Nursing

Manila, Philippines

1991 Cum Laude and Class Valedictorian

Bachelor of Science in Nursing Class of 1991

University of the Visayas

Cebu, Philippines

ACADEMIC SERVICE

University Service

• Vice-chair (current), DPU Presidential appointment to the DePaul University Institutional Review

Board, 3-year initial appointment, 2016-2019. Reappointment for a second term (2019-2022).

Vice-chair, (2020-2022) Reviews and approves all research-related activities of the university.

Performs the function of the Chair whenever the Chair is unable to perform his duties and

responsibilities.


• Member, Continuing Professional Unit Committee, member, 3-year term 2015-2018. Reviews all

applications for continuing professional education offered by DePaul University

• Member, DePaul Health Ad Hoc Committee, member (selected in May 2019). Charge: enhance

DePaul’s portfolio of health programs. Plan to become a permanent committee of the university.

Co-chairs election completed. Committee co-chairs are planning to have a meeting with the

Provost and President to define the charge of the Committee. Co-chairs are submitting a proposal

to make the Committee a permanent committee under the Faculty Council.

• Determine number of years per term.

College Service: College of Science and Health

• Chair, Strategic Planning Committee on Graduate Programs aka Graduate Research Excellence in

Academics & Training (GREAT) Committee (Chair, 2020- present; Member 2019-2020). The

Committee has two strategic priorities that include supporting doctoral programs to enhance the

reputation of the university and sustain its Carnegie classification and strengthening the existing

graduate and professional programs to ensure offerings, prepare our students for emerging career

opportunities, and respond to societal needs.

• Member, Teaching and Learning Committee (2018-present). Reviews all activities and issues

related to teaching and student learning experience. The TLC selects the recipient of the Annual

CSH Outstanding Teacher Award from the pool of nominated candidates.

• Member, CSH Strategic Planning Committee (2019-2020) – the committee was tasked to develop

a college-wide strategic plan, objectives , and implementation timeline. The committee had three

two-hours in-person meeting to identify the strategic goals and objectives for CSH. Several

iteration of the strategic plans were reviewed by all members of the CSH Planning Committee.

Consensus was reached and the Strategic Plan was finalized in Spring 2020.

• Member, Search Committee for the SON Director (July 2019-March 2020). The Search

Committee reviewed all applications and determined three eligible candidates using the candidate

review rubric. The rubric was developed by the Chair, Dr. Craig Klugman which guided the

Search Committee in sifting through the applicant files and moving the candidates who met the

minimum requirements and qualifications for the SON Director to the next step of the search

process. The use of rubric ensured a fair and just selection process. The

Department Service: School of Nursing Service

• Chair, Doctoral Study Committee (DSC), Currently serves as the Associate Co-Director for the

Doctor of Nursing Practice program and Co-Chair of the DSC. Oversees the implementation of

all curricular-related matters pertaining to the FNP, AGNP and DNP Completion tracks of the

SON doctoral program. Ensures full compliance with the university and CCNE accreditation

standards (Chair, 2018 – present; member, 2014-2018)

• Chair, Curriculum Committee in the Nursing Department. Served as the Chair for three years

from 2015 to 2018. Conducted MENP, RN to MS, and DNP curricular reviews. Led the NCLEX

Success Task Force Sub-Committee from 2016-2017. Participated in the preparation of the State

of Illinois CIPR report and the CCNE Accreditation Self-study Report. Involved in the


development of key strategies for RN to MS program implementation in 2017. Assisted the

Associate Director for the RN to MS program with the development and integration of FNP and

AGNP nurse practitioner tracks into the MS program of study in 2018. Completed a review and

updated all MENP course description and objectives with NCLEX blueprint mapping in 2016.

Accomplishment: The SON successfully met all the CCNE accreditation standards for MENP,

RN to MS, and DNP programs in February 2019. The DNP program received a 10-year fully

accredited program status (2019-2029).

• Curriculum Committee Member for one year from 2014-2015. Reviewed the NCLEX blueprint;

Reviewed and approved course syllabus changes for the MENP program. Participated in all

monthly meetings and contributed to the CCNE’s initial five-year accreditation of DNP program

(2014-2019).

• Member, Search Committee for the SON Tenure Track Faculty Position (2019-2020). The Search

Committee reviewed all applications for Assistant and Associate Professors Tenure Track

positions and determined eight eligible candidates using the candidate review rubric. The rubric

was developed by the Chair, Dr. Barbara Harris which guides the Search Committee in sifting

through the applicant files and moving the eight candidates who met the minimum requirements

and qualifications for the three TT positions to the next step of the search process. The use of

rubric ensured a fair and just selection process. The search was completed in July 2020.

• Co-chair, Human Relations Council, 2-year term, 2014-2016; Conducted and analyzed data on

civility quotient of faculty members; presented data during the 2014 faculty spring retreat

• Faculty Councilor, Sigma Theta Tau Honors Society of Nursing, DePaul University Zeta Sigma

Chapter; Fall 2015 – Summer 2018. Attended meetings and provided guidance and

recommendations to the Board related to all programs, events and community service activities of

the Zeta Sigma Chapter.

• Faculty Adviser to the Jonas Scholar; Sponsored by American Association of Colleges of

Nursing, Private, $22,500.00 for 2 years (Fall 2016- Summer 2018).

Service and Leadership Role to Professional Organizations

• President, January 1, 2017- December 31, 2018 and President-elect, January 1, 2016 to December 31, 2016 (three-year term); Chair of the Research Committee and Board Member, 2013 to

present. The Chicago Chapter of the Oncology Nursing Society.

Accomplishment: Recruited and sustained a new cadre of under 40 y.o., professional nursing

leaders in the CCONS Board of Directors


• Associate Editor – Clinical Journal of Oncology Nursing, June 2017 – June 2020. Reviews and edits all articles for the bi-monthly Supportive Care column of the journal

• Editorial Board Member and Peer Reviewer, JNPARR Journal- The Official Journal of the Philippines Nurses Association of America, July 2017 to July 2020

• Member, Board of Trustees (2013-2014) Oncology Nursing Society Foundation

• Editorial Board Member – The Oncology Nurse, June 2006 – June 2018

• Contributing writer – Advance for Nurse Practitioners - Men’s Health Column, 2005-2010

• Contributing editor - ONS Connect, formerly known as ONS News, 2005-2010

• Continuing Education Pilot Reviewer Oncology Nursing Society CEU Provider Unit 2005-2009

• Peer Review Board, member, Journal for the Advanced Practitioners in Oncology (JADPRO); 2015 - 2018

• Peer Review Board, member - Clinical Journal of Oncology Nursing, 2003 - present

• Peer Review Board, member - Oncology Nursing Forum, 2003- 2014

COMMUNITY SERVICE

• Leukemia and Lymphoma Society - Fundraising for Research - Raised over $7,000 to support LLS' research fund to find cure for lymphoma. October 2015.

• Myeloma Patient Support Group Founder and Organizer - Northwestern University Myeloma Program. Met every first Monday of the month. Provided myeloma

breakthrough information to myeloma patient support group members and their families.

Invited and organized guest speakers for the educational programs of the support group

throughout the year. July 2010 to January 2014.

• Leukemia & Lymphoma Society, Chicago Chapter. Volunteer; Guest speaker on topics related to myeloma; served as patient liaison for LLS. Distributed myeloma patient

education materials Facilitated patient financial assistance programs. July 2010 to

January 2014.

• Multiple Myeloma Fighters Seattle Patient Support Group. Guest speaker: Treatment decision making and quality of life. January 2008.

• International Myeloma Foundation – Volunteer. Provides education to myeloma patients and their family members. March 2002 –present.

• Men’s Health Network – Board of Directors, Member – July 2005 to 2010.

• Gilda’s Club, Chicago Chapter – Support Group Facilitator and Speaker, January 2006 – January 2014.

• Multiple Myeloma Research Foundation – Volunteer. Provided education to myeloma patients and their family members – March 2002 to January 2014.

• Medical Mission to Haiti – Health care volunteer, provided basic health care services to the underserved children and families in Port-au-Prince, Haiti – July 2000.


PROFESSIONAL ORGANIZATIONS MEMBERSHIP

• American N

joseph d. tariman, phd, rn, anp-bc, faan · 2020. 11. 27. · joseph d. tariman. phd, rn, anp-bc,...

Documents